Rapport Therapeutics (RAPP)'s 30-day implied volatility (IV30) was 73.9% at the close on October 23, 2026, up from 64.6% the day before, against a 52-week range of 50.2% to 111.3%. Its 20-day historical volatility was 69.8%.
Data as of October 23, 2026.